Loading…

ATG induction therapy: long‐term effects on Th1 but not on Th2 responses

Summary Antithymocyte globulin (ATG) induction therapy is associated with an increased long‐term risk of infection‐ and cancer‐related death. To analyze long‐term effects of ATG induction on lymphocyte function, we prospectively assessed CD4 helper function, B‐cell/monocyte and cytokine responses in...

Full description

Saved in:
Bibliographic Details
Published in:Transplant international 2005-02, Vol.18 (2), p.226-236
Main Authors: Weimer, Rolf, Staak, Anne, Süsal, Caner, Streller, Sabine, Yildiz, Sevgi, Pelzl, Steffen, Renner, Fabrice, Dietrich, Hartmut, Daniel, Volker, Rainer, Lucy, Kamali‐Ernst, Shirin, Ernst, Wolfgang, Padberg, Winfried, Opelz, Gerhard
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Antithymocyte globulin (ATG) induction therapy is associated with an increased long‐term risk of infection‐ and cancer‐related death. To analyze long‐term effects of ATG induction on lymphocyte function, we prospectively assessed CD4 helper function, B‐cell/monocyte and cytokine responses in 84 renal transplant recipients (ATG, n = 44) up to 1 year post‐transplant. A PWM‐driven allogeneic coculture system was used to assess helper function of CD4+ T cells and T‐cell‐dependent B‐cell responses. SAC I was used for T‐cell‐independent stimulation of B‐cell cultures. In vitro cytokine secretion and serum soluble CD30 (sCD30) were determined by enzyme‐linked immunosorbent assay (ELISA). ATG induced a persistent decrease of peripheral blood lymphocyte counts compared with non‐ATG treatment because of a predominant decrease of CD4+ T cells (4 months, 1 year; P 
ISSN:0934-0874
1432-2277
DOI:10.1111/j.1432-2277.2004.00047.x